COVID-19: Covaxin recommended for 2 to 18-year-olds in India

Covaxin, notably, will now become the country's first COVID-19 vaccine that can be administered to children.

New Delhi: In a major boost to India’s fight against COVID-19, the Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech’s Covaxin for 2 to 18-year-olds.

Covaxin, notably, will now become the country’s first COVID-19 vaccine that can be administered to children.

However, official comment on the same is awaited.

The development comes almost a week after sources claimed that Bharat Biotech, which completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age, has submitted the data to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for Emergency Use Authorisation for the jab.

Tags

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button